Back to User profile » Dr Andrew de la Torre
Papers published by Dr Andrew de la Torre:
Clinical Trial Report
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect
![](cr_data/cache/submission_images/s136000/136652/30_may_2017_figure3_200_200_90.jpg)
de la Torre AN, Contractor S, Castaneda I, Cathcart CS, Razdan D, Klyde D, Kisza P, Gonzales SF, Salazar AM
Journal of Hepatocellular Carcinoma 2017, 4:111-121
Published Date: 7 August 2017
Original Research
![Noteworthy comment: This paper reports on phase II of the study of Ambovex for HCC. It shows promising activity.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial
Salama H, Ahmad H, Elchagea I, Zekri AR, Medhat E, Bahnassy A, Lange M, Rabbat M, de la Torre AN, Punamiya P
Journal of Hepatocellular Carcinoma 2015, 2:79-89
Published Date: 22 June 2015